DRMA CIK: 1853816

Dermata Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
11.6
FY22:
6.94
FY23:
7.98
FY24:
3.53
FY25:
7.86
(positive)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
0
Total assets
Change from FY21 to FY25
millions USD
FY21:
11.6
FY22:
6.94
FY23:
7.98
FY24:
3.53
FY25:
7.86

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
1.52
FY22:
0.92
FY23:
1.62
FY24:
1.97
FY25:
1.64
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
10.1
FY22:
6.02
FY23:
6.36
FY24:
1.56
FY25:
6.22
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
11.6
FY22:
6.94
FY23:
7.98
FY24:
3.53
FY25:
7.86

All amounts in millions USD Data sources:SEC EDGARTwelve Data